Point72 (Difc) LTD Codexis, Inc. Transaction History

Point72 (Difc) LTD

$2.95 Trillion
Q3 2024

A detailed history of Point72 (Difc) LTD transactions in Codexis, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 1,341 shares of CDXS stock, worth $5,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,341

Holding current value

$5,203

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$2.62 - $3.71 $3,513 - $4,975	1,341 New	1,341 $4.13 Million
Q1 2024 May 15, 2024	BUY	$2.59 - $4.65 $7,736 - $13,889	2,987 New	2,987 $10.4 Million

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

Opaleye Management Inc. Boston, MA

8.77M
Shares

$34 Million
4.93% of portfolio
Casdin Capital, LLC New York, NY

8.1M
Shares

$31.4 Million
1.94% of portfolio
Black Rock Inc. New York, NY

6.79M
Shares

$26.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.15M
Shares

$16.1 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.97M
Shares

$11.5 Million
0.54% of portfolio

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $254M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Account